chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Fatigue, Rash
Clinical narrative: Rash; Fatigue; Redness; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash), FATIGUE (Fatigue) and ERYTHEMA (Redness) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH (Rash), FATIGUE (Fatigue) and ERYTHEMA (Redness). At the time of the report, RASH (Rash), FATIGUE (Fatigue) and ERYTHEMA (Redness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site mass, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: big red bulge of 2x2 inches at the injection site; It was warm to touch; big red bulge of 2x2 inches at the injection site; It is warm to touch itchy but not painful; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE MASS (big red bulge of 2x2 inches at the injection site), VACCINATION SITE WARMTH (It was warm to touch), VACCINATION SITE ERYTHEMA (big red bulge of 2x2 inches at the injection site) and VACCINATION SITE PRURITUS (It is warm to touch itchy but not painful) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LANSOPRAZOLE (PREVACID) for an unknown indication.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Feb-2021, the patient experienced VACCINATION SITE MASS (big red bulge of 2x2 inches at the injection site), VACCINATION SITE WARMTH (It was warm to touch), VACCINATION SITE ERYTHEMA (big red bulge of 2x2 inches at the injection site) and VACCINATION SITE PRURITUS (It is warm to touch itchy but not painful). At the time of the report, VACCINATION SITE MASS (big red bulge of 2x2 inches at the injection site), VACCINATION SITE WARMTH (It was warm to touch), VACCINATION SITE ERYTHEMA (big red bulge of 2x2 inches at the injection site) and VACCINATION SITE PRURITUS (It is warm to touch itchy but not painful) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Other concomitant medication reported was vitamins.   Reporter did not allow further contact
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Joint swelling, Lymphadenopathy, Musculoskeletal chest pain
Clinical narrative: swelling on the chest; swelling on shoulders; swelling of the lymph node on both side of the neck; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL CHEST PAIN (swelling on the chest), JOINT SWELLING (swelling on shoulders) and LYMPHADENOPATHY (swelling of the lymph node on both side of the neck) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Asthma.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced MUSCULOSKELETAL CHEST PAIN (swelling on the chest), JOINT SWELLING (swelling on shoulders) and LYMPHADENOPATHY (swelling of the lymph node on both side of the neck). On 28-Jan-2021, MUSCULOSKELETAL CHEST PAIN (swelling on the chest), JOINT SWELLING (swelling on shoulders) and LYMPHADENOPATHY (swelling of the lymph node on both side of the neck) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever for a few days following; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever for a few days following) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced PYREXIA (Fever for a few days following). At the time of the report, PYREXIA (Fever for a few days following) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Arrhythmia, Cardiac failure congestive, Carditis, Dyspnoea, Oedema peripheral
Clinical narrative: Patient says she developed shortness of breath, leg edema, progressive chest congestion  with productive cough.   Progressively worse until was admitted to the hospital on March 28,2021 with 'heart inflammation" , developed arrhythmia and subsequently diagnosed w congestive heart failure.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Productive cough, Pulmonary congestion
Clinical narrative: Patient says she developed shortness of breath, leg edema, progressive chest congestion  with productive cough.   Progressively worse until was admitted to the hospital on March 28,2021 with 'heart inflammation" , developed arrhythmia and subsequently diagnosed w congestive heart failure.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Anxiety, Condition aggravated, Diarrhoea, Fall
Clinical narrative: Stomach cramping and diarrhea, vomiting, couldn't stay awake, vertigo, falling, couldn't walk. Impending doom. I really felt I was going to die. Also, nothing got rid of my migraine that lasted 10 days.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Gait inability, Haemoglobin, Laboratory test, Migraine
Clinical narrative: Stomach cramping and diarrhea, vomiting, couldn't stay awake, vertigo, falling, couldn't walk. Impending doom. I really felt I was going to die. Also, nothing got rid of my migraine that lasted 10 days.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Somnolence, Vertigo, Vomiting
Clinical narrative: Stomach cramping and diarrhea, vomiting, couldn't stay awake, vertigo, falling, couldn't walk. Impending doom. I really felt I was going to die. Also, nothing got rid of my migraine that lasted 10 days.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Biliary colic, Dizziness, Nausea
Clinical narrative: nausea, diziness, galbladder pain
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Dizziness, Headache, Hyperhidrosis, Motion sickness
Clinical narrative: Shivering, chills, extreme headache, dizziness, motion sickness, fever, extreme sweating.
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Shivering, chills, extreme headache, dizziness, motion sickness, fever, extreme sweating.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus
Clinical narrative: Itchy; Arm was very red; Soreness; A spontaneous report was received from a healthcare professional concerning a 58-years-old  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events soreness/ vaccination site pain, arm was very red/ vaccination site erythema and itchy/ vaccination site pruritus.  The patient's medical history was not provided. Concomitant medications reported were aspirin, vitamin C and D, metamucil, crestor, colace for drug use for unknown indication.  On 27 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 029L20A) intramuscularly in the right arm for prophylaxis of COVID-19 infection.  On 8 Feb 2021, the patient experienced soreness at injection site. On 9 Feb 2021, the patient experienced the event arm was very red and itchy.  Treatment details included Benadryl.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events  soreness, arm was very red and itchy was unknown.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Cold-stimulus headache, Erythema, Flushing, Headache
Clinical narrative: Red welts; Face was red; Head ache either the front or the back of her head; had hot spot all over her face (cheeks, ears) about 102 F; Lips felt numb; Flush; Numbness in the left side of the face; Brain frog; Hot spot all over her face (cheeks, ears); Numbness in the left side of body hip and buttock/Went numb from elbow to wrist; Face was hot to touch; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA ORAL (Lips felt numb), FLUSHING (Flush), HYPOAESTHESIA (Numbness in the left side of the face), COLD-STIMULUS HEADACHE (Brain frog) and RASH MACULAR (Hot spot all over her face (cheeks, ears)) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Hashimoto's disease since an unknown date, Polycystic ovarian syndrome since an unknown date, Psoriatic arthritis since an unknown date and Hypothyroidism since an unknown date.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced HYPOAESTHESIA ORAL (Lips felt numb), FLUSHING (Flush), HYPOAESTHESIA (Numbness in the left side of the face), COLD-STIMULUS HEADACHE (Brain frog), RASH MACULAR (Hot spot all over her face (cheeks, ears)), HYPOAESTHESIA (Numbness in the left side of body hip and buttock/Went numb from elbow to wrist), HOT FLUSH (Face was hot to touch), ERYTHEMA (Face was red), HEADACHE (Head ache either the front or the back of her head) and PYREXIA (had hot spot all over her face (cheeks, ears) about 102 F). On 21-Jan-2021, the patient experienced URTICARIA (Red welts). At the time of the report, HYPOAESTHESIA ORAL (Lips felt numb), FLUSHING (Flush), HYPOAESTHESIA (Numbness in the left side of the face), COLD-STIMULUS HEADACHE (Brain frog), RASH MACULAR (Hot spot all over her face (cheeks, ears)), HYPOAESTHESIA (Numbness in the left side of body hip and buttock/Went numb from elbow to wrist), HOT FLUSH (Face was hot to touch), URTICARIA (Red welts), ERYTHEMA (Face was red), HEADACHE (Head ache either the front or the back of her head) and PYREXIA (had hot spot all over her face (cheeks, ears) about 102 F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Jan-2021, Body temperature: 102 (High) Fahrenheit. In 2021, SARS-CoV-2 test: negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment related information has been reported.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Hot flush, Hypoaesthesia, Hypoaesthesia oral, Pyrexia, Rash macular
Clinical narrative: Red welts; Face was red; Head ache either the front or the back of her head; had hot spot all over her face (cheeks, ears) about 102 F; Lips felt numb; Flush; Numbness in the left side of the face; Brain frog; Hot spot all over her face (cheeks, ears); Numbness in the left side of body hip and buttock/Went numb from elbow to wrist; Face was hot to touch; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA ORAL (Lips felt numb), FLUSHING (Flush), HYPOAESTHESIA (Numbness in the left side of the face), COLD-STIMULUS HEADACHE (Brain frog) and RASH MACULAR (Hot spot all over her face (cheeks, ears)) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Hashimoto's disease since an unknown date, Polycystic ovarian syndrome since an unknown date, Psoriatic arthritis since an unknown date and Hypothyroidism since an unknown date.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced HYPOAESTHESIA ORAL (Lips felt numb), FLUSHING (Flush), HYPOAESTHESIA (Numbness in the left side of the face), COLD-STIMULUS HEADACHE (Brain frog), RASH MACULAR (Hot spot all over her face (cheeks, ears)), HYPOAESTHESIA (Numbness in the left side of body hip and buttock/Went numb from elbow to wrist), HOT FLUSH (Face was hot to touch), ERYTHEMA (Face was red), HEADACHE (Head ache either the front or the back of her head) and PYREXIA (had hot spot all over her face (cheeks, ears) about 102 F). On 21-Jan-2021, the patient experienced URTICARIA (Red welts). At the time of the report, HYPOAESTHESIA ORAL (Lips felt numb), FLUSHING (Flush), HYPOAESTHESIA (Numbness in the left side of the face), COLD-STIMULUS HEADACHE (Brain frog), RASH MACULAR (Hot spot all over her face (cheeks, ears)), HYPOAESTHESIA (Numbness in the left side of body hip and buttock/Went numb from elbow to wrist), HOT FLUSH (Face was hot to touch), URTICARIA (Red welts), ERYTHEMA (Face was red), HEADACHE (Head ache either the front or the back of her head) and PYREXIA (had hot spot all over her face (cheeks, ears) about 102 F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Jan-2021, Body temperature: 102 (High) Fahrenheit. In 2021, SARS-CoV-2 test: negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment related information has been reported.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Urticaria
Clinical narrative: Red welts; Face was red; Head ache either the front or the back of her head; had hot spot all over her face (cheeks, ears) about 102 F; Lips felt numb; Flush; Numbness in the left side of the face; Brain frog; Hot spot all over her face (cheeks, ears); Numbness in the left side of body hip and buttock/Went numb from elbow to wrist; Face was hot to touch; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA ORAL (Lips felt numb), FLUSHING (Flush), HYPOAESTHESIA (Numbness in the left side of the face), COLD-STIMULUS HEADACHE (Brain frog) and RASH MACULAR (Hot spot all over her face (cheeks, ears)) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Hashimoto's disease since an unknown date, Polycystic ovarian syndrome since an unknown date, Psoriatic arthritis since an unknown date and Hypothyroidism since an unknown date.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced HYPOAESTHESIA ORAL (Lips felt numb), FLUSHING (Flush), HYPOAESTHESIA (Numbness in the left side of the face), COLD-STIMULUS HEADACHE (Brain frog), RASH MACULAR (Hot spot all over her face (cheeks, ears)), HYPOAESTHESIA (Numbness in the left side of body hip and buttock/Went numb from elbow to wrist), HOT FLUSH (Face was hot to touch), ERYTHEMA (Face was red), HEADACHE (Head ache either the front or the back of her head) and PYREXIA (had hot spot all over her face (cheeks, ears) about 102 F). On 21-Jan-2021, the patient experienced URTICARIA (Red welts). At the time of the report, HYPOAESTHESIA ORAL (Lips felt numb), FLUSHING (Flush), HYPOAESTHESIA (Numbness in the left side of the face), COLD-STIMULUS HEADACHE (Brain frog), RASH MACULAR (Hot spot all over her face (cheeks, ears)), HYPOAESTHESIA (Numbness in the left side of body hip and buttock/Went numb from elbow to wrist), HOT FLUSH (Face was hot to touch), URTICARIA (Red welts), ERYTHEMA (Face was red), HEADACHE (Head ache either the front or the back of her head) and PYREXIA (had hot spot all over her face (cheeks, ears) about 102 F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Jan-2021, Body temperature: 102 (High) Fahrenheit. In 2021, SARS-CoV-2 test: negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment related information has been reported.
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy
Clinical narrative: This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnant) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On an unknown date, the patient experienced EXPOSURE DURING PREGNANCY (Pregnant). At the time of the report, EXPOSURE DURING PREGNANCY (Pregnant) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No treatment related information has been reported.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Illness, Myalgia
Clinical narrative: quite sick from the second dose; Ragging headache; fatigue; bad body ache; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (quite sick from the second dose), HEADACHE (Ragging headache), FATIGUE (fatigue) and MYALGIA (bad body ache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 2 dosage form. On 08-Feb-2021, the patient experienced ILLNESS (quite sick from the second dose), HEADACHE (Ragging headache), FATIGUE (fatigue) and MYALGIA (bad body ache). At the time of the report, ILLNESS (quite sick from the second dose), HEADACHE (Ragging headache), FATIGUE (fatigue) and MYALGIA (bad body ache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Upon in internal review on 21 May 2021, the age was corrected to unknown age. No concomitant medications were reported. No treatment related information has been reported.   Most recent FOLLOW-UP information incorporated above includes: On 23-Apr-2021: The outcome of events were updated to recovered. The reporter did not allow further contact.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Musculoskeletal stiffness, Pruritus, Rash, Vaccination site erythema, Vaccination site rash
Clinical narrative: Arm got stiff; It itches; rash all over her body/it started spreading all over her body/red spots all over her body; rash on her right arm where she received the vaccine; red at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (Arm got stiff), PRURITUS (It itches), RASH (rash all over her body/it started spreading all over her body/red spots all over her body), VACCINATION SITE RASH (rash on her right arm where she received the vaccine) and VACCINATION SITE ERYTHEMA (red at the injection site) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     The patient's past medical history included Lupus erythematosus since an unknown date. Concomitant products included HYDROXYCHLOROQUINE for Lupus erythematosus, LEVOTHYROXINE for Lupus syndrome.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MUSCULOSKELETAL STIFFNESS (Arm got stiff), PRURITUS (It itches), RASH (rash all over her body/it started spreading all over her body/red spots all over her body), VACCINATION SITE RASH (rash on her right arm where she received the vaccine) and VACCINATION SITE ERYTHEMA (red at the injection site). At the time of the report, MUSCULOSKELETAL STIFFNESS (Arm got stiff), PRURITUS (It itches), RASH (rash all over her body/it started spreading all over her body/red spots all over her body), VACCINATION SITE RASH (rash on her right arm where she received the vaccine) and VACCINATION SITE ERYTHEMA (red at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment related information has been reported.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore arm) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     Concomitant products included APIXABAN (ELIQUIS) and ATORVASTATIN CALCIUM (LIPITOR) for an unknown indication.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced VACCINATION SITE PAIN (sore arm). The patient was treated with PARACETAMOL (TYLENOL) from 06-Feb-2021 to 07-Feb-2021 at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Vaccination site pain
Clinical narrative: dizzy spells/lightheaded; headaches; arm hurt a little; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizzy spells/lightheaded), HEADACHE (headaches) and VACCINATION SITE PAIN (arm hurt a little) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high and High cholesterol. Concomitant products included LOSARTAN, ATORVASTATIN, VENLAFAXINE and MULTIVITAMINS [VITAMINS NOS] for an unknown indication.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Jan-2021, the patient experienced DIZZINESS (dizzy spells/lightheaded), HEADACHE (headaches) and VACCINATION SITE PAIN (arm hurt a little). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, DIZZINESS (dizzy spells/lightheaded), HEADACHE (headaches) and VACCINATION SITE PAIN (arm hurt a little) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Nasal congestion, Oropharyngeal pain, Productive cough, Rhinorrhoea
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat), RHINORRHOEA (runny nose), NASAL CONGESTION (congestion) and PRODUCTIVE COUGH (coughing clear flehm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat), RHINORRHOEA (runny nose), NASAL CONGESTION (congestion) and PRODUCTIVE COUGH (coughing clear flehm). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, OROPHARYNGEAL PAIN (sore throat), RHINORRHOEA (runny nose), NASAL CONGESTION (congestion) and PRODUCTIVE COUGH (coughing clear flehm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medication was reported.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chills, Headache, Myalgia, Nausea
Clinical narrative: Night Sweating; Chills; Constant Headache; Nausea; Body ache; Covid 19; This spontaneous case was reported by a consumer and describes the occurrence of NIGHT SWEATS (Night Sweating), COVID-19 (Covid 19), CHILLS (Chills), HEADACHE (Constant Headache) and NAUSEA (Nausea) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced COVID-19 (Covid 19). On an unknown date, the patient experienced NIGHT SWEATS (Night Sweating), CHILLS (Chills), HEADACHE (Constant Headache), NAUSEA (Nausea) and MYALGIA (Body ache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, NIGHT SWEATS (Night Sweating), CHILLS (Chills), HEADACHE (Constant Headache), NAUSEA (Nausea) and MYALGIA (Body ache) had not resolved and COVID-19 (Covid 19) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Feb-2021, COVID-19: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Night sweats
Clinical narrative: Night Sweating; Chills; Constant Headache; Nausea; Body ache; Covid 19; This spontaneous case was reported by a consumer and describes the occurrence of NIGHT SWEATS (Night Sweating), COVID-19 (Covid 19), CHILLS (Chills), HEADACHE (Constant Headache) and NAUSEA (Nausea) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced COVID-19 (Covid 19). On an unknown date, the patient experienced NIGHT SWEATS (Night Sweating), CHILLS (Chills), HEADACHE (Constant Headache), NAUSEA (Nausea) and MYALGIA (Body ache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, NIGHT SWEATS (Night Sweating), CHILLS (Chills), HEADACHE (Constant Headache), NAUSEA (Nausea) and MYALGIA (Body ache) had not resolved and COVID-19 (Covid 19) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Feb-2021, COVID-19: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chest pain, Dizziness, Dyspnoea, Headache
Clinical narrative: Slightly elevated heart rate; Weakness; Dizziness; Headache; Dizziness; chest pain; Shortness of breath; A spontaneous report was received from a consumer concerning a 28-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events dizziness, chest pain, shortness of breath/dyspnoea, headache, weakness/asthenia, slightly elevated heart rate/heart rate increased.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 8 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) intramuscularly for prophylaxis of COVID-19 infection.  On 8 Feb 2021, thirty minutes after receiving the vaccine the patient experienced the event dizziness, chest pain, shortness of breath, headache. The patient visited emergency room on 8 Feb 2021 for the events.  On 9 Feb 2021, the patient experienced the event(s) weakness, slightly elevated heart rate and dizziness worsened.  Treatment details included diphenhydramine and breathing treatment.  Action taken with mRNA-1273 in response to the events was not reported.   On 9 Feb 2021, the outcome of events dizziness, chest pain, shortness of breath, headache, weakness, slightly elevated heart rate was unknown.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased
Clinical narrative: Slightly elevated heart rate; Weakness; Dizziness; Headache; Dizziness; chest pain; Shortness of breath; A spontaneous report was received from a consumer concerning a 28-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events dizziness, chest pain, shortness of breath/dyspnoea, headache, weakness/asthenia, slightly elevated heart rate/heart rate increased.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 8 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) intramuscularly for prophylaxis of COVID-19 infection.  On 8 Feb 2021, thirty minutes after receiving the vaccine the patient experienced the event dizziness, chest pain, shortness of breath, headache. The patient visited emergency room on 8 Feb 2021 for the events.  On 9 Feb 2021, the patient experienced the event(s) weakness, slightly elevated heart rate and dizziness worsened.  Treatment details included diphenhydramine and breathing treatment.  Action taken with mRNA-1273 in response to the events was not reported.   On 9 Feb 2021, the outcome of events dizziness, chest pain, shortness of breath, headache, weakness, slightly elevated heart rate was unknown.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Eye swelling, Fatigue, Headache
Clinical narrative: Dental abscess; Swelling of left eye; Swelling of left cheek; Headache; Muscle pain; Chills; Joint pain; Fever; Fatigue; This spontaneous case was reported by a health care professional and describes the occurrence of TOOTH ABSCESS (Dental abscess), HEADACHE (Headache), MYALGIA (Muscle pain), CHILLS (Chills) and ARTHRALGIA (Joint pain) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.  On 22-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced HEADACHE (Headache), MYALGIA (Muscle pain), CHILLS (Chills), ARTHRALGIA (Joint pain), PYREXIA (Fever) and FATIGUE (Fatigue). On 31-Jan-2021, the patient experienced TOOTH ABSCESS (Dental abscess) with EYE SWELLING (Swelling of left eye) and SWELLING FACE (Swelling of left cheek). In February 2021, TOOTH ABSCESS (Dental abscess) had resolved. At the time of the report, HEADACHE (Headache), CHILLS (Chills), ARTHRALGIA (Joint pain), PYREXIA (Fever) and FATIGUE (Fatigue) had resolved and MYALGIA (Muscle pain) had not resolved.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not reported.  Treatment medication was not reported.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia, Swelling face, Tooth abscess
Clinical narrative: Dental abscess; Swelling of left eye; Swelling of left cheek; Headache; Muscle pain; Chills; Joint pain; Fever; Fatigue; This spontaneous case was reported by a health care professional and describes the occurrence of TOOTH ABSCESS (Dental abscess), HEADACHE (Headache), MYALGIA (Muscle pain), CHILLS (Chills) and ARTHRALGIA (Joint pain) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.  On 22-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced HEADACHE (Headache), MYALGIA (Muscle pain), CHILLS (Chills), ARTHRALGIA (Joint pain), PYREXIA (Fever) and FATIGUE (Fatigue). On 31-Jan-2021, the patient experienced TOOTH ABSCESS (Dental abscess) with EYE SWELLING (Swelling of left eye) and SWELLING FACE (Swelling of left cheek). In February 2021, TOOTH ABSCESS (Dental abscess) had resolved. At the time of the report, HEADACHE (Headache), CHILLS (Chills), ARTHRALGIA (Joint pain), PYREXIA (Fever) and FATIGUE (Fatigue) had resolved and MYALGIA (Muscle pain) had not resolved.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not reported.  Treatment medication was not reported.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure fluctuation, Chest pain, Dyspnoea
Clinical narrative: Chest pain; Blood pressure fluctuating; shortness of breath; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (Chest pain), BLOOD PRESSURE FLUCTUATION (Blood pressure fluctuating) and DYSPNOEA (shortness of breath) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     The patient's past medical history included Foot surgery (2 weeks before vaccination). Concurrent medical conditions included Allergy NOS.    On 21-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Feb-2021, the patient experienced CHEST PAIN (Chest pain), BLOOD PRESSURE FLUCTUATION (Blood pressure fluctuating) and DYSPNOEA (shortness of breath). At the time of the report, CHEST PAIN (Chest pain), BLOOD PRESSURE FLUCTUATION (Blood pressure fluctuating) and DYSPNOEA (shortness of breath) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported.  Treatment medication was not reported.   Reporter did not allow further contact
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: Tested positive for covid; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive for covid) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced COVID-19 (Tested positive for covid). On 28-Jan-2021, COVID-19 (Tested positive for covid) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Jan-2021, SARS-CoV-2 test: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment related information has been reported.   This case was linked to MOD-2021-052870 (Patient Link).
Age: 34.0
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Dyspnoea, Pulmonary pain
Clinical narrative: Pain in lungs; Pain at top of breath; Felt pain in back; Joint pain in right ankle; Joint pain in right wrist; This spontaneous case was reported by a consumer and describes the occurrence of PULMONARY PAIN (Pain in lungs), DYSPNOEA (Pain at top of breath), BACK PAIN (Felt pain in back), ARTHRALGIA (Joint pain in right ankle) and ARTHRALGIA (Joint pain in right wrist) in a 34-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     No Medical History information was reported.  On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Feb-2021 at 2:00 AM, the patient experienced PULMONARY PAIN (Pain in lungs), DYSPNOEA (Pain at top of breath), BACK PAIN (Felt pain in back), ARTHRALGIA (Joint pain in right ankle) and ARTHRALGIA (Joint pain in right wrist). The patient was treated with IBUPROFEN for Adverse event, at a dose of 800 milligram. On 08-Feb-2021, ARTHRALGIA (Joint pain in right ankle) and ARTHRALGIA (Joint pain in right wrist) had resolved. At the time of the report, PULMONARY PAIN (Pain in lungs), DYSPNOEA (Pain at top of breath) and BACK PAIN (Felt pain in back) outcome was unknown. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant medication was not reported.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: vaccination site rash; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (vaccination site rash) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE RASH (vaccination site rash). At the time of the report, VACCINATION SITE RASH (vaccination site rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment related information has been reported.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Muscle tightness
Clinical narrative: can't shovel the snow and at night when he lays on his back, toss and turn due to the tightness; A lot of fatigue; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE TIGHTNESS (can't shovel the snow and at night when he lays on his back, toss and turn due to the tightness) and FATIGUE (A lot of fatigue) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced MUSCLE TIGHTNESS (can't shovel the snow and at night when he lays on his back, toss and turn due to the tightness) and FATIGUE (A lot of fatigue). At the time of the report, MUSCLE TIGHTNESS (can't shovel the snow and at night when he lays on his back, toss and turn due to the tightness) and FATIGUE (A lot of fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment related information has been reported
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: Tired for a few days; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Tired for a few days) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L2*A) for COVID-19 vaccination.     The patient's past medical history included Anaphylactic reaction to drug (Amifostine 20 years ago). Previously administered products included for an unreported indication: AMIFOSTINE (20 years ago) since an unknown date. Concurrent medical conditions included Cancer. Concomitant products included OLAPARIB (LYNPARZA) for Cancer.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FATIGUE (Tired for a few days). At the time of the report, FATIGUE (Tired for a few days) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) dosing remained unchanged.     Concomitant medication included additional unspecified medications.  Treatment medication was not reported.   This case was linked to MOD-2021-027614 (Patient Link).
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal discomfort, Constipation, Decreased appetite, Diarrhoea
Clinical narrative: diarrhea; constipated; No appetite, could not eat anything; stomach worrying him; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), CONSTIPATION (constipated), DECREASED APPETITE (No appetite, could not eat anything) and ABDOMINAL DISCOMFORT (stomach worrying him) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Prostatic disorder NOS (Taking pressure medicine for his prostate). Concomitant products included OMEPRAZOLE (PRILOSEC [OMEPRAZOLE]) and ACETYLSALICYLIC ACID (ASPIRIN 81) for an unknown indication.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (diarrhea), CONSTIPATION (constipated), DECREASED APPETITE (No appetite, could not eat anything) and ABDOMINAL DISCOMFORT (stomach worrying him). At the time of the report, DIARRHOEA (diarrhea), CONSTIPATION (constipated), DECREASED APPETITE (No appetite, could not eat anything) and ABDOMINAL DISCOMFORT (stomach worrying him) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment related information has been reported
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Dizziness, Headache, Illness, Muscle spasms
Clinical narrative: pain in my pinky finger; extremely ill; nauseous; headache; dizzy; diarrhea; sore arm; muscles started twisting in her legs; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), MUSCLE SPASMS (muscles started twisting in her legs), PAIN IN EXTREMITY (pain in my pinky finger), NAUSEA (nauseous) and DIZZINESS (dizzy) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LEVOTHYROXINE, LORATADINE and COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]) for an unknown indication.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm), MUSCLE SPASMS (muscles started twisting in her legs), NAUSEA (nauseous), DIZZINESS (dizzy), DIARRHOEA (diarrhea) and HEADACHE (headache). On an unknown date, the patient experienced PAIN IN EXTREMITY (pain in my pinky finger) and ILLNESS (extremely ill). At the time of the report, PAIN IN EXTREMITY (sore arm), MUSCLE SPASMS (muscles started twisting in her legs), PAIN IN EXTREMITY (pain in my pinky finger), NAUSEA (nauseous), DIZZINESS (dizzy), DIARRHOEA (diarrhea), HEADACHE (headache) and ILLNESS (extremely ill) outcome was unknown.       The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Treatment medication was not reported.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain in extremity
Clinical narrative: pain in my pinky finger; extremely ill; nauseous; headache; dizzy; diarrhea; sore arm; muscles started twisting in her legs; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), MUSCLE SPASMS (muscles started twisting in her legs), PAIN IN EXTREMITY (pain in my pinky finger), NAUSEA (nauseous) and DIZZINESS (dizzy) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LEVOTHYROXINE, LORATADINE and COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]) for an unknown indication.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm), MUSCLE SPASMS (muscles started twisting in her legs), NAUSEA (nauseous), DIZZINESS (dizzy), DIARRHOEA (diarrhea) and HEADACHE (headache). On an unknown date, the patient experienced PAIN IN EXTREMITY (pain in my pinky finger) and ILLNESS (extremely ill). At the time of the report, PAIN IN EXTREMITY (sore arm), MUSCLE SPASMS (muscles started twisting in her legs), PAIN IN EXTREMITY (pain in my pinky finger), NAUSEA (nauseous), DIZZINESS (dizzy), DIARRHOEA (diarrhea), HEADACHE (headache) and ILLNESS (extremely ill) outcome was unknown.       The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Treatment medication was not reported.
Sex: F
Vaccine: COVID19
Symptoms: Skin swelling
Clinical narrative: Some areas on my skin that are quite a little large that I have that I would like to report; This spontaneous case was reported by a consumer and describes the occurrence of SKIN SWELLING (Some areas on my skin that are quite a little large that I have that I would like to report) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SKIN SWELLING (Some areas on my skin that are quite a little large that I have that I would like to report). At the time of the report, SKIN SWELLING (Some areas on my skin that are quite a little large that I have that I would like to report) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.  Concomitant medications were not provided. Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 05-Jun-2021: Follow-up information received on 05-JUN-2021 contains significant information- event outcome added. Patient stated her events resolved in 3days and she did not took any medication.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of this event, a causal relationship cannot be excluded.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: Arm ache; Pain on the legs; headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm ache), PAIN IN EXTREMITY (Pain on the legs) and HEADACHE (headache) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm ache), PAIN IN EXTREMITY (Pain on the legs) and HEADACHE (headache). At the time of the report, PAIN IN EXTREMITY (Arm ache), PAIN IN EXTREMITY (Pain on the legs) and HEADACHE (headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant and  treatment medications were provided.   Most recent FOLLOW-UP information incorporated above includes: On 12-Jul-2021: Event outcome updated